- $537.26m
- $508.88m
- $280.52m
- 97
- 47
- 71
- 82
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 225 | 198 | 224 | 263 | 281 |
Cost of Revenue | |||||
Gross Profit | 159 | 145 | 173 | 202 | 213 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 223 | 195 | 216 | 239 | 254 |
Operating Profit | 2.65 | 3.06 | 8.1 | 23.7 | 26.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.592 | 0.796 | 6.08 | 22.1 | 25.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.02 | -9.44 | 13.6 | 18.4 | 17.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.02 | -9.44 | 13.6 | 18.4 | 17.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.02 | -9.44 | 13.6 | 18.4 | 17.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.65 | 0.948 | 1.26 | 1.27 |